Morgan KP - Search Results

1

A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agents.

Caron WP, Morgan KP, Zamboni BA, Zamboni WC. Caron WP, et al. Among authors: morgan kp. Clin Cancer Res. 2013 Jun 15;19(12):3309-15. doi: 10.1158/1078-0432.CCR-12-3649. Epub 2013 Apr 25. Clin Cancer Res. 2013. PMID: 23620407

2

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.

Morgan KP, Buie LW, Savage SW. Morgan KP, et al. Ann Pharmacother. 2012 Feb;46(2):276-81. doi: 10.1345/aph.1Q333. Epub 2012 Jan 31. Ann Pharmacother. 2012. PMID: 22298599 Review.

3

Impact of an integrated oral chemotherapy program on patient adherence.

Morgan KP, Muluneh B, Deal AM, Amerine LB. Morgan KP, et al. J Oncol Pharm Pract. 2018 Jul;24(5):332-336. doi: 10.1177/1078155217703792. Epub 2017 Apr 5. J Oncol Pharm Pract. 2018. PMID: 28379068

4

Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors.

Johnston H, Deal AM, Morgan KP, Patel B, Milowsky MI, Rose TL. Johnston H, et al. Among authors: morgan kp. Clin Genitourin Cancer. 2023 Jun;21(3):357-365. doi: 10.1016/j.clgc.2023.02.007. Epub 2023 Feb 16. Clin Genitourin Cancer. 2023. PMID: 37012148

5

Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.

Bates JS, Auten J, Sketch MR, Patel T, Clark SM, Morgan KP, Muluneh B, McLaughlin JE, Pinelli NR, Foster MC, Amerine L. Bates JS, et al. Among authors: morgan kp. J Oncol Pharm Pract. 2019 Jun;25(4):896-902. doi: 10.1177/1078155219832644. Epub 2019 Feb 26. J Oncol Pharm Pract. 2019. PMID: 30808278

6

Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.

Lentz KL, Clark SM, Ayarza M, Liu B, Morgan KP, Wind LS, Hairston A. Lentz KL, et al. Among authors: morgan kp. J Oncol Pharm Pract. 2020 Mar;26(2):406-412. doi: 10.1177/1078155219859644. Epub 2019 Jul 9. J Oncol Pharm Pract. 2020. PMID: 31288633

7

Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.

Morgan KP, Snavely AC, Wind LS, Buie LW, Grilley-Olson J, Walko CM, Weiss J. Morgan KP, et al. Ann Pharmacother. 2014 Jul;48(7):863-869. doi: 10.1177/1060028014533303. Epub 2014 Apr 28. Ann Pharmacother. 2014. PMID: 24778426

8

Response to Selpercatinib in a Patient With Recurrent Glioblastoma and RET Amplification.

Czech C, Chen A, Morgan KP, Zamora C, El-Refai S, Poynter N, Khagi S. Czech C, et al. Among authors: morgan kp. J Natl Compr Canc Netw. 2022 Sep;20(9):966-971. doi: 10.6004/jnccn.2022.7030. J Natl Compr Canc Netw. 2022. PMID: 36075388

9

Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.

Palmer S, Tillman F 3rd, Sharma P, Auten J, Owen K, Clark SM, Morgan KP. Palmer S, et al. Among authors: morgan kp. Ann Pharmacother. 2021 Mar;55(3):303-310. doi: 10.1177/1060028020953501. Epub 2020 Aug 27. Ann Pharmacother. 2021. PMID: 32847379

10

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome.

File DM, Morgan KP, Khagi S. File DM, et al. Among authors: morgan kp. JCO Precis Oncol. 2020 Jul 23;4:PO.20.00112. doi: 10.1200/PO.20.00112. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923878 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters